Are we sure that #Crohn's patients with 1 risk factor for #POR need immunoprophylaxis after surgery? An @IGIBD1 effort has tried to answer this question.
Link to the paper in the first comment👇
The new IG-IBD study “Therapies for IBD do not pose additional risks for adverse outcomes of SARS-CoV-2 infection” is now published.
Thanks to the “COVID-19 IG-IBD study group”!!!
https://t.co/n7rA4FCsDJ
Nella video-pillola di oggi, la Dott.ssa Pugliese ci anticipa alcune delle tematiche che verranno affrontate in occasione del XI Congresso Nazionale IGIBD, che si terrà in modalità virtuale dal 29 novembre al 5 dicembre 2020.